Disclosure Under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015

GCCL Transaction Completion Letter

Newspaper Advertisement – Interim Dividend

Outcome of Board Meeting held on
26th September, 2025

Board Meeting Intimation

Credit Rating Rationale – CRISIL

Transfer of the Company’s Consumer Care business

Intimation Regarding Upfront Payment Received

Newspaper Advertisement

Update acquisition of securities of O2 Renewable Energy XXIV Private Limited

Q1 FY 2026 Results – Newspaper Advertisement

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015

Result of Postal Ballot by remote e-voting & Scrutinizer’s Report

Newspaper Advertisement – Postal Ballot Notice

Notice of Postal Ballot – Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Incorporation of Glenmark Consumer Care Limited

Grant of ESOPs

Result of Postal Ballot by remote e-voting & Scrutinizer’s Report

Glenmark Pharmaceuticals Inc., USA to launch Mixed Amphetamines Immediate-Release Tablets

Appointment of Senior Management Personnel of the Company

Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)

Newspaper Advertisement – Postal Ballot Notice

Notice of Postal Ballot – Disclosure under Regulation 30 of the SEBI LODR Regulations, 2015

Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the Philippines

Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)

Glenmark Pharma Expands Cardiometabolic Portfolio with the Launch of Empagliflozin and its Fixed-Drug Combinations in India

Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)

Glenmark Pharmaceuticals Inc., USA launches acquires and launches Acetylcysteine Injection 6 gm-30 mL (200 mg-mL) Single-Dose Vials

Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial